The Vertical Group is a healthcare-focused venture capital firm that invests in early-stage medical technology companies, including medical devices, diagnostics, and digital health solutions. Their strategy involves leveraging deep industry expertise to identify and support disruptive innovations addressing unmet medical needs.
Portfolio
11
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
JW
Jack W. Lasersohn
General Partner
JE
John E. Runnells
General Partner
RB
Richard B. Emmitt
General Partner
TM
Tony M. Chou
General Partner
Stage Distribution
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Opkey | Series B | $47M | Aug 2024 |
| Alida Biosciences | Series A | $7.5M | Jun 2024 |
| Backflip | Series A | $15M | Apr 2024 |
| Roofr | Series A | $23.5M | Oct 2023 |
| Inbox Health | Series B | $22.5M | May 2023 |
| Soci | Growth | $120M | Mar 2023 |
| MicroTransponder | Series E | $73M | Sep 2022 |
| Delix Therapeutics | Series A | $70M | Sep 2021 |
| IONpath, Inc. | Series B | $18M | Sep 2020 |
| Soci | Series C | $15M | Dec 2019 |
| Ordermark | Series B | $9.5M | Sep 2018 |
Top Co-Investors
Blossom Street Ventures2 shared
JMI Equity1 shared
RiverPark Ventures1 shared
Techstars1 shared
Matchstick Ventures1 shared
PeakSpan1 shared
Grayhawk Capital1 shared
Ten Coves Capital1 shared
FirstMark Capital1 shared
LiveOak Venture Partners1 shared
Revel Partners1 shared
RA Capital Management1 shared
Apeiron Investment Group1 shared
Casa Verde Capital1 shared
Dolby Family Ventures1 shared
Palo Santo1 shared
Presight Capital1 shared
PsyMed1 shared
Samsara BioCapital1 shared
ND Capital1 shared
Last updated: 1 March 2026